2024 Q3 Form 10-Q Financial Statement

#000090725424000088 Filed on August 01, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2024 Q2
Revenue $67.29M $66.94M
YoY Change 5.52% 5.08%
Cost Of Revenue $17.73M $17.26M
YoY Change 2.13% 4.95%
Gross Profit $49.56M $49.68M
YoY Change 6.79% 5.12%
Gross Profit Margin 73.65% 74.21%
Selling, General & Admin $5.680M $6.102M
YoY Change 9.65% 7.47%
% of Gross Profit 11.46% 12.28%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $12.07M $12.00M
YoY Change -0.2% -0.93%
% of Gross Profit 24.36% 24.16%
Operating Expenses $17.77M $18.28M
YoY Change 1.76% 2.32%
Operating Profit $31.79M $31.40M
YoY Change 9.83% 6.82%
Interest Expense $12.26M $12.31M
YoY Change -1.81% -0.44%
% of Operating Profit 38.55% 39.18%
Other Income/Expense, Net
YoY Change
Pretax Income $19.59M $19.49M
YoY Change 17.25% 13.39%
Income Tax
% Of Pretax Income
Net Earnings $14.48M $14.45M
YoY Change 12.97% 9.77%
Net Earnings / Revenue 21.52% 21.58%
Basic Earnings Per Share $0.48 $0.48
Diluted Earnings Per Share $0.48 $0.48
COMMON SHARES
Basic Shares Outstanding 24.14M shares 23.98M shares
Diluted Shares Outstanding 24.16M shares 24.12M shares

Balance Sheet

Concept 2024 Q3 2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $7.197M $6.863M
YoY Change 9.05% -40.18%
Cash & Equivalents $7.197M $6.863M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables $59.82M $53.33M
Other Receivables $0.00 $0.00
Total Short-Term Assets $67.02M $60.19M
YoY Change 5.54% -5.09%
LONG-TERM ASSETS
Property, Plant & Equipment $2.008B $1.975B
YoY Change 8.46% 9.26%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $25.47M $25.83M
YoY Change 10.28% 13.31%
Total Long-Term Assets $2.046B $2.011B
YoY Change 7.83% 9.12%
TOTAL ASSETS
Total Short-Term Assets $67.02M $60.19M
Total Long-Term Assets $2.046B $2.011B
Total Assets $2.113B $2.072B
YoY Change 7.76% 8.65%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $57.21M $70.12M
YoY Change -1.53% 36.65%
Accrued Expenses $2.000M $2.200M
YoY Change -25.93% -24.14%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $82.57M $95.56M
YoY Change -0.88% 24.61%
LONG-TERM LIABILITIES
Long-Term Debt $1.493B $1.443B
YoY Change 11.14% 11.47%
Other Long-Term Liabilities $28.89M $20.42M
YoY Change 25.6% -6.5%
Total Long-Term Liabilities $1.522B $1.463B
YoY Change 11.38% 11.17%
TOTAL LIABILITIES
Total Short-Term Liabilities $82.57M $95.56M
Total Long-Term Liabilities $1.522B $1.463B
Total Liabilities $1.604B $1.559B
YoY Change 10.68% 11.91%
SHAREHOLDERS EQUITY
Retained Earnings -$297.5M -$294.9M
YoY Change 4.38% 4.99%
Common Stock $241.0K $241.0K
YoY Change 0.0% 0.42%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $341.8M $345.7M
YoY Change
Total Liabilities & Shareholders Equity $2.113B $2.072B
YoY Change 7.76% 8.65%

Cashflow Statement

Concept 2024 Q3 2024 Q2
OPERATING ACTIVITIES
Net Income $14.48M $14.45M
YoY Change 12.97% 9.77%
Depreciation, Depletion And Amortization $12.07M $12.00M
YoY Change -0.2% -0.93%
Cash From Operating Activities $26.49M $32.13M
YoY Change 62.51% -1.42%
INVESTING ACTIVITIES
Capital Expenditures $54.82M $44.81M
YoY Change 14.44% -20.29%
Acquisitions
YoY Change
Other Investing Activities $0.00 $181.0K
YoY Change
Cash From Investing Activities -$54.82M -$44.63M
YoY Change 14.44% -20.61%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 28.66M 12.28M
YoY Change 7.75% -47.25%
NET CHANGE
Cash From Operating Activities 26.49M 32.13M
Cash From Investing Activities -54.82M -44.63M
Cash From Financing Activities 28.66M 12.28M
Net Change In Cash 334.0K -216.0K
YoY Change -106.68% -36.28%
FREE CASH FLOW
Cash From Operating Activities $26.49M $32.13M
Capital Expenditures $54.82M $44.81M
Free Cash Flow -$28.33M -$12.68M
YoY Change -10.35% -46.33%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.88
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.88
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
24082887 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
24082887 shares
us-gaap Share Based Compensation
ShareBasedCompensation
724000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
843000 usd
us-gaap Provision For Loan Lease And Other Losses
ProvisionForLoanLeaseAndOtherLosses
515000 usd
us-gaap Provision For Loan Lease And Other Losses
ProvisionForLoanLeaseAndOtherLosses
-27000 usd
us-gaap Increase Decrease In Accounts And Notes Receivable
IncreaseDecreaseInAccountsAndNotesReceivable
-4401000 usd
CY2024Q2 us-gaap Assets
Assets
2071597000 usd
us-gaap Revenues
Revenues
126758000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
32731000 usd
us-gaap Gross Profit
GrossProfit
94027000 usd
bfs Noncash Interest Expense Accretion And Amortization Of Deferred Finance Fees
NoncashInterestExpenseAccretionAndAmortizationOfDeferredFinanceFees
24099000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
24130000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
10946000 usd
us-gaap Profit Loss
ProfitLoss
34852000 usd
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
99366000 usd
CY2023Q2 us-gaap Assets
Assets
1906694000 usd
CY2024Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.48
CY2024Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.48
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.43
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.43
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
521802000 usd
CY2023Q1 us-gaap Stock Issued During Period Shares Dividend Reinvestment Plan
StockIssuedDuringPeriodSharesDividendReinvestmentPlan
13227 shares
CY2023Q1 us-gaap Stock Issued During Period Value Dividend Reinvestment Plan
StockIssuedDuringPeriodValueDividendReinvestmentPlan
543000 usd
CY2023Q1 us-gaap Stock Issued During Period Shares Share Based Compensation
StockIssuedDuringPeriodSharesShareBasedCompensation
699 shares
CY2023Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
290000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
17663000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
-2014000 usd
CY2023Q1 us-gaap Dividends Common Stock
DividendsCommonStock
19651000 usd
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
515835000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Dividend Reinvestment Plan
StockIssuedDuringPeriodValueDividendReinvestmentPlan
544000 usd
CY2023Q2 us-gaap Stock Issued During Period Shares Share Based Compensation
StockIssuedDuringPeriodSharesShareBasedCompensation
3104000 shares
CY2023Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
553000 usd
CY2023Q2 us-gaap Profit Loss
ProfitLoss
17189000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
2401000 usd
CY2023Q2 us-gaap Dividends Common Stock
DividendsCommonStock
19679000 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
514044000 usd
us-gaap Profit Loss
ProfitLoss
37753000 usd
us-gaap Profit Loss
ProfitLoss
34852000 usd
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
181000 usd
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
0 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
24030000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
24130000 usd
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
1145000 usd
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
1122000 usd
us-gaap Increase Decrease In Accounts And Notes Receivable
IncreaseDecreaseInAccountsAndNotesReceivable
-2189000 usd
us-gaap Increase Decrease In Deferred Leasing Fees
IncreaseDecreaseInDeferredLeasingFees
4174000 usd
us-gaap Increase Decrease In Deferred Leasing Fees
IncreaseDecreaseInDeferredLeasingFees
2486000 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-3323000 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-3315000 usd
bfs Increase Decrease In Accounts Payable Accrued Expenses And Other Liabilities
IncreaseDecreaseInAccountsPayableAccruedExpensesAndOtherLiabilities
2967000 usd
bfs Increase Decrease In Accounts Payable Accrued Expenses And Other Liabilities
IncreaseDecreaseInAccountsPayableAccruedExpensesAndOtherLiabilities
3875000 usd
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
2332000 usd
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
1333000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
65959000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
68692000 usd
us-gaap Payments To Acquire Commercial Real Estate
PaymentsToAcquireCommercialRealEstate
10889000 usd
us-gaap Payments To Acquire Commercial Real Estate
PaymentsToAcquireCommercialRealEstate
14109000 usd
us-gaap Payments To Develop Real Estate Assets
PaymentsToDevelopRealEstateAssets
79486000 usd
us-gaap Payments To Develop Real Estate Assets
PaymentsToDevelopRealEstateAssets
85257000 usd
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
181000 usd
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
0 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-90194000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-99366000 usd
us-gaap Proceeds From Issuance Of Secured Debt
ProceedsFromIssuanceOfSecuredDebt
100000000 usd
us-gaap Proceeds From Issuance Of Secured Debt
ProceedsFromIssuanceOfSecuredDebt
15300000 usd
us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
68036000 usd
us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
25614000 usd
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
51000000 usd
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
78000000 usd
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
91000000 usd
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
23000000 usd
us-gaap Proceeds From Construction Loans Payable
ProceedsFromConstructionLoansPayable
64302000 usd
us-gaap Proceeds From Construction Loans Payable
ProceedsFromConstructionLoansPayable
28421000 usd
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
1947000 usd
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
421000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
1162000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
1087000 usd
us-gaap Proceeds From Issuance Of Common Limited Partners Units
ProceedsFromIssuanceOfCommonLimitedPartnersUnits
13275000 usd
us-gaap Proceeds From Issuance Of Common Limited Partners Units
ProceedsFromIssuanceOfCommonLimitedPartnersUnits
0 usd
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
28428000 usd
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
28336000 usd
us-gaap Payments Of Dividends Minority Interest
PaymentsOfDividendsMinorityInterest
12040000 usd
us-gaap Payments Of Dividends Minority Interest
PaymentsOfDividendsMinorityInterest
10972000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
22691000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
28868000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1544000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1806000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
8407000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
13279000 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6863000 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
11473000 usd
us-gaap Interest Paid Net
InterestPaidNet
23972000 usd
us-gaap Interest Paid Net
InterestPaidNet
22676000 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
43494000 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
26364000 usd
CY2024Q2 bfs Minimum Percentage Of Taxable Income Distribution To Shareholders
MinimumPercentageOfTaxableIncomeDistributionToShareholders
0.90
bfs Number Of Subsidiaries
NumberOfSubsidiaries
2 subsidiary
CY2024Q2 us-gaap Number Of Stores
NumberOfStores
34 store
us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. The most significant estimates and assumptions relate to collectability of operating lease receivables and impairment of real estate properties. Actual results could differ from those estimates.</span></div>
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Reclassifications</span></div><div style="margin-top:5pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain reclassifications have been made to the prior year financial statements to conform to the presentation used as of and for the six months ended June 30, 2024.</span></div>
CY2024Q2 us-gaap Development In Process
DevelopmentInProcess
615166000 usd
CY2023Q4 us-gaap Development In Process
DevelopmentInProcess
514553000 usd
CY2024Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2100000 usd
CY2024Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
2200000 usd
CY2024Q2 us-gaap Deferred Costs Leasing Net
DeferredCostsLeasingNet
25800000 usd
CY2023Q4 us-gaap Deferred Costs Leasing Net
DeferredCostsLeasingNet
23700000 usd
CY2024Q2 us-gaap Deferred Costs Leasing Accumulated Amortization
DeferredCostsLeasingAccumulatedAmortization
54600000 usd
CY2023Q4 us-gaap Deferred Costs Leasing Accumulated Amortization
DeferredCostsLeasingAccumulatedAmortization
53700000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
21900000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
22000000 usd
us-gaap Cost Of Property Repairs And Maintenance
CostOfPropertyRepairsAndMaintenance
9000000.0 usd
us-gaap Cost Of Property Repairs And Maintenance
CostOfPropertyRepairsAndMaintenance
7100000 usd
CY2024Q2 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
200000 usd
CY2024Q2 us-gaap Area Of Real Estate Property
AreaOfRealEstateProperty
2543 sqft
CY2024Q2 us-gaap Limited Partners Capital Account Units Outstanding
LimitedPartnersCapitalAccountUnitsOutstanding
9900000 shares
us-gaap Debt Instrument Basis Spread On Variable Rate1
DebtInstrumentBasisSpreadOnVariableRate1
0.0010
CY2022Q3 bfs Number Of Interest Rate Swaps
NumberOfInterestRateSwaps
2 swap
CY2024Q2 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
1460000000 usd
CY2024Q2 us-gaap Longterm Debt Percentage Bearing Fixed Interest Amount
LongtermDebtPercentageBearingFixedInterestAmount
1230000000 usd
CY2024Q2 us-gaap Longterm Debt Percentage Bearing Variable Interest Amount
LongtermDebtPercentageBearingVariableInterestAmount
236000000 usd
CY2024Q2 us-gaap Real Estate Gross At Carrying Value
RealEstateGrossAtCarryingValue
1610000000 usd
CY2023Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
1410000000 usd
CY2023Q4 us-gaap Longterm Debt Percentage Bearing Fixed Interest Amount
LongtermDebtPercentageBearingFixedInterestAmount
1130000000 usd
CY2023Q4 us-gaap Longterm Debt Percentage Bearing Variable Interest Amount
LongtermDebtPercentageBearingVariableInterestAmount
276000000.0 usd
CY2023Q4 us-gaap Real Estate Gross At Carrying Value
RealEstateGrossAtCarryingValue
1520000000 usd
CY2024Q2 bfs Long Term Debt Maturities Repayments Of Principal And Balloon Payments Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalAndBalloonPaymentsRemainderOfFiscalYear
16886000 usd
CY2024Q2 bfs Long Term Debt Maturities Repayments Of Principal And Balloon Payments In Year One
LongTermDebtMaturitiesRepaymentsOfPrincipalAndBalloonPaymentsInYearOne
290059000 usd
CY2024Q2 bfs Long Term Debt Maturities Repayments Of Principal And Balloon Payments In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalAndBalloonPaymentsInYearTwo
164738000 usd
CY2024Q2 bfs Long Term Debt Maturities Repayments Of Principal And Balloon Payments In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalAndBalloonPaymentsInYearThree
129390000 usd
CY2024Q2 bfs Long Term Debt Maturities Repayments Of Principal And Balloon Payments In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalAndBalloonPaymentsInYearFour
47957000 usd
CY2024Q2 bfs Long Term Debt Maturities Repayments Of Principal And Balloon Payments In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalAndBalloonPaymentsInYearFive
56003000 usd
CY2024Q2 bfs Long Term Debt Maturities Repayments Of Principal And Balloon Payments After Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalAndBalloonPaymentsAfterYearFive
757516000 usd
CY2024Q2 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
1462549000 usd
CY2024Q2 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
19945000 usd
CY2024Q2 us-gaap Long Term Debt
LongTermDebt
1442604000 usd
CY2024Q2 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
19900000 usd
CY2023Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
19300000 usd
CY2024Q2 us-gaap Accumulated Amortization Deferred Finance Costs
AccumulatedAmortizationDeferredFinanceCosts
10500000 usd
CY2023Q4 us-gaap Accumulated Amortization Deferred Finance Costs
AccumulatedAmortizationDeferredFinanceCosts
10600000 usd
CY2024Q2 us-gaap Interest Expense Debt
InterestExpenseDebt
18400000 usd
CY2023Q2 us-gaap Interest Expense Debt
InterestExpenseDebt
16267000 usd
us-gaap Interest Expense Debt
InterestExpenseDebt
36485000 usd
us-gaap Interest Expense Debt
InterestExpenseDebt
31780000 usd
CY2024Q2 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
582000 usd
CY2023Q2 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
564000 usd
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
1145000 usd
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
1122000 usd
CY2024Q2 us-gaap Interest Costs Capitalized Adjustment
InterestCostsCapitalizedAdjustment
6677000 usd
CY2023Q2 us-gaap Interest Costs Capitalized Adjustment
InterestCostsCapitalizedAdjustment
4472000 usd
us-gaap Interest Costs Capitalized Adjustment
InterestCostsCapitalizedAdjustment
12845000 usd
us-gaap Interest Costs Capitalized Adjustment
InterestCostsCapitalizedAdjustment
8614000 usd
CY2024Q2 us-gaap Interest Expense
InterestExpense
12305000 usd
CY2023Q2 us-gaap Interest Expense
InterestExpense
12359000 usd
us-gaap Interest Expense
InterestExpense
24785000 usd
us-gaap Interest Expense
InterestExpense
24288000 usd
CY2024Q2 us-gaap Interest Income Operating
InterestIncomeOperating
38000 usd
CY2023Q2 us-gaap Interest Income Operating
InterestIncomeOperating
81000 usd
us-gaap Interest Income Operating
InterestIncomeOperating
70000 usd
us-gaap Interest Income Operating
InterestIncomeOperating
189000 usd
CY2024Q2 bfs Noncash Interest Expense Accretion And Amortization Of Deferred Finance Fees
NoncashInterestExpenseAccretionAndAmortizationOfDeferredFinanceFees
12267000 usd
CY2023Q2 bfs Noncash Interest Expense Accretion And Amortization Of Deferred Finance Fees
NoncashInterestExpenseAccretionAndAmortizationOfDeferredFinanceFees
12278000 usd
bfs Noncash Interest Expense Accretion And Amortization Of Deferred Finance Fees
NoncashInterestExpenseAccretionAndAmortizationOfDeferredFinanceFees
24715000 usd
bfs Noncash Interest Expense Accretion And Amortization Of Deferred Finance Fees
NoncashInterestExpenseAccretionAndAmortizationOfDeferredFinanceFees
24099000 usd
us-gaap Income Loss Attributable To Noncontrolling Interest
IncomeLossAttributableToNoncontrollingInterest
9700000 usd
us-gaap Income Loss Attributable To Noncontrolling Interest
IncomeLossAttributableToNoncontrollingInterest
8200000 usd
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
24112000 shares
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
24043000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
24103000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
24034000 shares
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
24116000 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
24044000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
24107000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
24035000 shares
us-gaap Defined Contribution Plan Maximum Annual Contributions Per Employee Percent
DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent
0.06
us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
235500 usd
us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
231400 usd
bfs Deferred Compensation Arrangement With Individual Contributions By Plan Participants Percentage Of Salary Maximum
DeferredCompensationArrangementWithIndividualContributionsByPlanParticipantsPercentageOfSalaryMaximum
0.02
us-gaap Deferred Compensation Arrangement With Individual Contributions By Employer
DeferredCompensationArrangementWithIndividualContributionsByEmployer
110600 usd
us-gaap Deferred Compensation Arrangement With Individual Contributions By Employer
DeferredCompensationArrangementWithIndividualContributionsByEmployer
132400 usd
bfs Deferred Compensation Arrangement With Individual Employer Contribution Percentage Deferred Compensation
DeferredCompensationArrangementWithIndividualEmployerContributionPercentageDeferredCompensation
3
bfs Deferred Compensation Arrangement With Individual Employer Contribution Percentage Deferred Compensation
DeferredCompensationArrangementWithIndividualEmployerContributionPercentageDeferredCompensation
3
CY2024Q2 us-gaap Deferred Compensation Arrangement With Individual Recorded Liability
DeferredCompensationArrangementWithIndividualRecordedLiability
3200000 usd
CY2023Q4 us-gaap Deferred Compensation Arrangement With Individual Recorded Liability
DeferredCompensationArrangementWithIndividualRecordedLiability
3300000 usd
us-gaap Deferred Compensation Arrangement With Individual Shares Issued
DeferredCompensationArrangementWithIndividualSharesIssued
4933 shares
CY2024Q2 us-gaap Deferred Compensation Arrangement With Individual Shares Issued
DeferredCompensationArrangementWithIndividualSharesIssued
120324 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1820000 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
49.41
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
1197380 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0
bfs Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodIntrinsicValue
0 usd
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
4375 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
33.79
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
15306 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
475125 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
51.01
bfs Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodIntrinsicValue
0 usd
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1340500 shares
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
48.89
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
570298 usd
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1100750 shares
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
50.75
CY2024Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
213815 usd
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
4375 shares
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
4375 shares
CY2023Q3 us-gaap Share Price
SharePrice
36.77
CY2023Q3 bfs Share Based Compensation Arrangement By Share Based Payment Award Options Grants Since Inception
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsSinceInception
1100000 shares
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y3M18D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P4Y8M12D
bfs Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Rights Minimum Required Percentage Of Shares Granted That Will Vest
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRightsMinimumRequiredPercentageOfSharesGrantedThatWillVest
0.90
CY2024Q2 us-gaap Notes Payable Fair Value Disclosure
NotesPayableFairValueDisclosure
997800000 usd
CY2023Q4 us-gaap Notes Payable Fair Value Disclosure
NotesPayableFairValueDisclosure
957900000 usd
CY2024Q2 us-gaap Notes Payable
NotesPayable
1230000000 usd
CY2023Q4 us-gaap Notes Payable
NotesPayable
1130000000 usd
CY2024Q2 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
828000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
2919000 usd
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
3239000 usd
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
1302000 usd
CY2024Q2 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification Before Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
-604000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification Before Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
-518000 usd
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification Before Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
-1212000 usd
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification Before Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
-915000 usd
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 segment
CY2024Q2 us-gaap Revenues
Revenues
66943000 usd
CY2024Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
17264000 usd
CY2024Q2 us-gaap Gross Profit
GrossProfit
49679000 usd
CY2024Q2 bfs Noncash Interest Expense Accretion And Amortization Of Deferred Finance Fees
NoncashInterestExpenseAccretionAndAmortizationOfDeferredFinanceFees
12267000 usd
CY2024Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
12001000 usd
CY2024Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6102000 usd
CY2024Q2 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
181000 usd
CY2024Q2 us-gaap Profit Loss
ProfitLoss
19490000 usd
CY2024Q2 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
44625000 usd
CY2024Q2 us-gaap Assets
Assets
2071597000 usd
CY2023Q2 us-gaap Revenues
Revenues
63709000 usd
CY2023Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
16450000 usd
CY2023Q2 us-gaap Gross Profit
GrossProfit
47259000 usd
CY2023Q2 bfs Noncash Interest Expense Accretion And Amortization Of Deferred Finance Fees
NoncashInterestExpenseAccretionAndAmortizationOfDeferredFinanceFees
12278000 usd
CY2023Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
12114000 usd
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5678000 usd
CY2023Q2 us-gaap Profit Loss
ProfitLoss
17189000 usd
CY2023Q2 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
56210000 usd
CY2023Q2 us-gaap Assets
Assets
1906694000 usd
us-gaap Revenues
Revenues
133635000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
35433000 usd
us-gaap Gross Profit
GrossProfit
98202000 usd
bfs Noncash Interest Expense Accretion And Amortization Of Deferred Finance Fees
NoncashInterestExpenseAccretionAndAmortizationOfDeferredFinanceFees
24715000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
24030000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
11885000 usd
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
181000 usd
us-gaap Profit Loss
ProfitLoss
37753000 usd
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
90194000 usd

Files In Submission

Name View Source Status
0000907254-24-000088-index-headers.html Edgar Link pending
0000907254-24-000088-index.html Edgar Link pending
0000907254-24-000088.txt Edgar Link pending
0000907254-24-000088-xbrl.zip Edgar Link pending
bfs-06302024xex31.htm Edgar Link pending
bfs-06302024xex32.htm Edgar Link pending
bfs-06302024xex99a.htm Edgar Link pending
bfs-20240630.htm Edgar Link pending
bfs-20240630.xsd Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
bfs-20240630_def.xml Edgar Link unprocessable
bfs-20240630_lab.xml Edgar Link unprocessable
bfs-20240630_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
bfs-20240630_htm.xml Edgar Link completed
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
bfs-20240630_cal.xml Edgar Link unprocessable